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TO THE EDITOR
The involvement of retroviruses and
more specifically of viruses belonging
to the human T-cell lymphotropic virus
(HTLV) family in cutaneous T-cell
lymphomas’ (CTCL) pathomechanisms
remains a fiercely debated issue. In-
deed, this hypothesis has remained
attractive owing to the presence of a
number of similarities between subsets
of HTLV-1-associated adult T-cell leu-
kemia and erythrodermic forms of
CTCL. Overall, studies conducted in
Europe have been generally negative
(Bazarbachi et al., 1993, 1997) with the
notable exception of a report from Italy,
which claimed the isolation of a new
retrovirus distantly related to HTLV-1
(then designated HTLV-V) from a con-
tinuous cell line derived from a patient
with CD4þ Tac CTCL/leukemia as
well as in other patients with CTCL
(Manzari et al., 1987). This alleged
breakthrough has not been confirmed
by subsequent studies, including further
investigations conducted by the same
team. Another, more recent, report
identified HTLV-1 tax-like sequences
in blood and saliva from Russian CTCL
patients, and established that these
sequences were indeed expressed up
to the protein level (Morozov et al.,
2005). In addition, a significant propor-
tion of USA-based investigations
seemed to find out precise clues regard-
ing the presence of retroviral agents
close to HTLV-1 in skin lesions and/or
peripheral blood in CTCL, and some
authors have considered it reasonable
to conclude that mycosis fungoides/
Se´zary syndrome was an HTLV-asso-
ciated disease (Hall et al., 1991; Pan-
cake et al., 1995; Khan et al., 1996)
even though other studies originating
from the same geographical area have
remained negative, as have been most
of European studies (Wood et al.,
1997). The discrepancy in the results
and concepts developed in these re-
ports is puzzling, and the fact that these
different studies have been conducted
with heterogeneous tools makes it
difficult to apply strict comparisons.
Furthermore, virtually all tools used in
these studies, of which most of them
have been conducted more than 10
years ago, were either poorly specific
(serological tests or identification of
viral particles, for instance), or were
instead specifically targeting HTLV-1
and notably the tax sequence, thereby
significantly reducing the chances to
uncover even slightly divergent retro-
viruses. To overcome this difficulty, we
used a recently described powerful
semi-nested DNA amplification method
(Kim et al., 2006), allowing the ampli-
fication of a sequence from the HTLV
envelope gene located in the envelope
receptor-binding domain (Kim et al.,
2004). This PCR amplification of the
highly variable envelope region, as
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opposed to the conserved tax sequence,
was designed to function with all
known Primate T-cell lymphotropic
viruses (PTLV) (Kim et al., 2006). We
applied this method to a wide search of
PTLV sequences in a series of CTCL skin
and blood samples.
Genomic DNA was extracted from
the cutaneous lesions and from the
peripheral blood mononuclear cells of
30 patients with CTCL diagnosed on
usual clinical, histological, immunolo-
gical, and molecular grounds (21 with
mycosis fungoides stage Ib–IIb and nine
with Se´zary syndrome). Informed, writ-
ten patients’ consent and institutional
approval for experiments were not
required by French laws for the search
of viral genetic material on tissue and
blood samples obtained earlier for other
purposes, and the experiments were
conducted in accordance with Helsinki
Guidelines. For amplification of HTLV-
related sequences, up to 1 mg of geno-
mic DNA was subjected to semi-nested
envelope receptor-binding domain
amplification under touchdown PCR
conditions as described earlier (Kim
et al., 2006). A schematic representa-
tion of the strategy used is depicted in
Figure 1.
Amplification of all 60 skin and blood
samples from patients was all negative
except for a single skin sample obtained
from a patient with Se´zary syndrome,
wherein an amplimer of the apparent
expected size (around 200 bp) was
observed (not shown). However, subse-
quent sequencing of the amplified frag-
ment displayed a non-related sequence,
indicative of an isolated non-specific
amplification. Conversely, positive con-
trols, including HTLV-1 and 2, as well
as STLV-3 sequences resulted in a suc-
cessful amplification with the expected
size and sequence of the amplimer, thus
ensuring the validity and specificity of
the results.
This study had been designed as an
attempt to further assess the discrepan-
cies between different studies with
regard to the possible involvement of
lymphotropic retroviruses in CTCL
pathomechanisms. One hypothesis
was that different viruses were present
in different parts of the world and that
tools specifically targeting HTLV-1
could not efficiently detect every pos-
sible PTLV variant. Accordingly, it
became necessary to use a new, power-
ful, and highly sensitive tool that would
ensure the detection of all known PTLV,
including the recently described HTLV-4
(Switzer et al., 2009). This study overall
confirmed earlier generally negative
reports with regard to an HTLV-related
etiology for these syndromes. One
hypothesis to explain the discrepancy
in detecting HTLV in these diseases is
hat initial, long-lasting stages of a
particular, indolent (smoldering) subset
of adult T-cell leukemia might have
been mistaken with CTCL in studies
issuing positive results with regard to
HTLV-1-related virus search. However,
in spite of limited similarities, most
clinical and histological data are spe-
cific enough to prevent such confusion,
especially in patients with protracted
disease, and this possibility is thus very
unlikely.
Eventually, our results do not defini-
tively rule out the involvement of a
PTLV in the oncogenesis of CTCL, as
the intervention of a defective virus
primarily or secondarily lacking the
envelope gene remains theoretically
possible (Hall et al., 1991; Morozov
et al., 2005). Accordingly, studies must
keep going in this still attractive per-
spective.
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Figure 1. Schematic representation of the human T-cell lymphotropic virus (HTLV)-1 proviral genome,
the encoded envelope glycoprotein, and the PCR amplification strategy. The gag, pro, pol, env, and tax
genes are indicated with their respective open reading frames shown as bold lines on top of the provirus.
Arrows indicate the localization of the primers across the envelope glycoprotein with the amino acids
corresponding to the primer sequence shown on top, using the single letter amino acid code and
numbering starting from the first signal peptide (SP) methionine of the HTLV-1 Env (envelope) precursor.
A and B delineate the amplicons obtained after the first and second round of the semi-nested PCR
protocol, respectively. SU, surface component of the envelope glycoprotein; and TM, transmembrane
component of the envelope glycoprotein.
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